{"id":"https://openalex.org/W2953501979","doi":"https://doi.org/10.1158/1538-7445.am2019-2199","title":"Abstract 2199: BOS172738: A novel highly potent and selective RET kinase inhibitor in Phase 1 clinical development","display_name":"Abstract 2199: BOS172738: A novel highly potent and selective RET kinase inhibitor in Phase 1 clinical development","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2953501979","doi":"https://doi.org/10.1158/1538-7445.am2019-2199","mag":"2953501979"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-2199","doi":"https://doi.org/10.1158/1538-7445.am2019-2199","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-2199","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036643432","display_name":"Mitchell Keegan","orcid":"https://orcid.org/0009-0001-0186-9002","observed_orcids":["https://orcid.org/0009-0001-0186-9002"]},"institutions":[{"id":"https://openalex.org/I4405270318","display_name":"Boston Pharmaceuticals (United States)","ror":"https://ror.org/00fk46e73","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270318"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mitchell Keegan","raw_affiliation_strings":["Boston Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113792391","display_name":"Keith Wilcoxen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270318","display_name":"Boston Pharmaceuticals (United States)","ror":"https://ror.org/00fk46e73","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270318"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith Wilcoxen","raw_affiliation_strings":["Boston Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270318"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086652615","display_name":"Peter T. C. Ho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270318","display_name":"Boston Pharmaceuticals (United States)","ror":"https://ror.org/00fk46e73","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270318"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter T. Ho","raw_affiliation_strings":["Boston Pharmaceuticals, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Pharmaceuticals, Cambridge, MA","institution_ids":["https://openalex.org/I4405270318"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405270318"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"2199","last_page":"2199"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ret-inhibitors","display_name":"RET inhibitors","score":0.8550000190734863},{"id":"https://openalex.org/keywords/ret-fusion","display_name":"RET fusion","score":0.6800000071525574},{"id":"https://openalex.org/keywords/kif5b-ret","display_name":"KIF5B-RET","score":0.8960000276565552},{"id":"https://openalex.org/keywords/ccdc6-ret","display_name":"CCDC6-RET","score":0.7960000038146973},{"id":"https://openalex.org/keywords/ret-m918t-mutation","display_name":"RET M918T mutation","score":0.7570000290870667},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7979999780654907},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9490000009536743},{"id":"https://openalex.org/keywords/papillary-thyroid-carcinoma","display_name":"papillary thyroid carcinoma","score":0.871999979019165},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.6010000109672546},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7019110321998596},{"id":"https://openalex.org/C2780381907","wikidata":"https://www.wikidata.org/wiki/Q198728","display_name":"Ponatinib","level":5,"score":0.6319730281829834},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6292436718940735},{"id":"https://openalex.org/C2908751931","wikidata":"https://www.wikidata.org/wiki/Q415976","display_name":"Proto-Oncogene Proteins c-ret","level":5,"score":0.616212785243988},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5877799987792969},{"id":"https://openalex.org/C111829193","wikidata":"https://www.wikidata.org/wiki/Q1108970","display_name":"Fusion gene","level":3,"score":0.4970226585865021},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.47801530361175537},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4188724160194397},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37857216596603394},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3356987237930298},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3317939043045044},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.3273337185382843},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2759266197681427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2403000295162201},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.20567050576210022},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14974519610404968},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14131471514701843},{"id":"https://openalex.org/C160539049","wikidata":"https://www.wikidata.org/wiki/Q3064187","display_name":"Neurotrophic factors","level":3,"score":0.0},{"id":"https://openalex.org/C185856081","wikidata":"https://www.wikidata.org/wiki/Q14916286","display_name":"Glial cell line-derived neurotrophic factor","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-2199","doi":"https://doi.org/10.1158/1538-7445.am2019-2199","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-2199","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3168256479","https://openalex.org/W2947371837","https://openalex.org/W4414478544","https://openalex.org/W2787516164","https://openalex.org/W2885963255","https://openalex.org/W1552238219","https://openalex.org/W2402687425","https://openalex.org/W2943916363","https://openalex.org/W4415237418","https://openalex.org/W2568773335"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"RET":[2,25,64,69,82,97,110,144,168,170,271,341,352,359,390],"gene":[3,9],"alterations":[4],"including":[5,17,274],"point":[6],"mutations":[7,57,171],"and":[8,21,48,50,60,85,113,120,132,146,163,169,182,213,282,289,302,339,388],"fusions":[10,145],"have":[11,106],"been":[12,73,103],"detected":[13],"in":[14,58,79,108,114,129,133,136,197,228,231,244,249,264,368,393],"multiple":[15],"cancers,":[16,273],"colorectal":[18],"cancer,":[19],"NSCLC":[20,59,84,291],"various":[22],"thyroid":[23,87],"cancers.":[24],"fusion":[26,42,272,353],"events":[27],"involve":[28],"the":[29,55,230,402],"kinesin":[30],"family":[31],"member":[32],"5B":[33],"(KIF5B-RET),":[34],"as":[35,37,45,355,357],"well":[36,356],"a":[38,204,235,265,286,337,349,369],"number":[39,266],"of":[40,68,234,267,270,308,351,401],"other":[41,61],"partners":[43],"such":[44],"CCDC6,":[46],"TRIM33,":[47],"NCOA,":[49],"are":[51],"considered":[52],"to":[53,105,202,220],"be":[54],"driver":[56],"tumors":[62,327],"harboring":[63],"fusions.":[65],"Selective":[66],"inhibitors":[67],"kinase":[70,98,153,342,391],"recently":[71],"has":[72,101],"associated":[74],"with":[75,81,157,172,207,285,311,344],"durable":[76,303],"objective":[77],"responses":[78],"patients":[80],"gene-altered":[83],"papillary":[86],"carcinoma.":[88],"BOS172738":[89,158,184,199,216,260,299,318,335,363],"(formerly":[90],"DS-5010)":[91],"is":[92,336,364],"an":[93],"orally":[94],"available":[95],"small-molecule":[96],"inhibitor":[99,111,206,392],"that":[100,334],"previously":[102],"shown":[104],"potent":[107,208,301,321,338,387],"vitro":[109,130,232],"activity":[112,209,248,347],"vivo":[115,134],"potency":[116,166,219],"against":[117,159,210,348],"transfected":[118],"allograft":[119],"xenograft":[121,139],"models.":[122],"In":[123,295],"this":[124,195],"study,":[125],"we":[126],"discuss":[127],"additional":[128],"characterization":[131],"efficacy":[135],"patient":[137],"derived":[138],"(PDX)":[140],"models":[141,269,278],"driven":[142],"by":[143],"emergent":[147],"resistant":[148,358],"mutations.":[149,362],"Results:":[150],"An":[151],"expanded":[152],"profile":[154],"was":[155,200,261],"conducted":[156],"over":[160,189],"450":[161],"kinases,":[162],"demonstrated":[164,186,217,300,320],"exquisite":[165],"for":[167,178,405],"Kd":[173],"values":[174],"\u2264":[175],"1":[176,371,395],"nM":[177],"RETwt,":[179],"RET(M918T),":[180],"RET(V804L)":[181],"RET(V804M).":[183],"also":[185,262,319],"high":[187],"selectivity":[188,196],"KDR":[190,212],"(>300":[191],"fold).":[192],"To":[193],"confirm":[194],"vitro,":[198],"compared":[201],"ponatinib,":[203],"multikinase":[205],"both":[211],"RET.":[214],"While":[215],"similar":[218],"ponatinib":[221],"(IC50":[222,254],"0.5":[223],"\u00b5M":[224,256],"vs.":[225],"0.3":[226],"\u00b5M)":[227],"inhibiting":[229],"proliferation":[233],"NCO4-RET":[236],"human":[237],"CRC":[238,276],"cell":[239],"line":[240],"(CR1520),":[241],"it":[242],"resulted":[243],"significantly":[245],"less":[246],"anti-proliferative":[247],"HUVEC":[250],"normal":[251],"endothelial":[252],"cells":[253],"2.9":[255],"vs":[257],"0.2":[258],"\u00b5M).":[259],"evaluated":[263,367],"PDX":[268,277,292],"three":[275],"(CR2518:CCDC6-RET,":[279],"CR1520:":[280],"NCOA4-RET":[281],"CR2545:":[283],"CCDC6-RET":[284],"V804M":[287],"mutation)":[288],"one":[290],"model":[293],"(CTG-0838:KIF5B-RET).":[294],"all":[296],"cases":[297],"tested,":[298],"tumor":[304,312,322],"regression":[305,323],"at":[306,315],"doses":[307],"30":[309],"mg/kg,":[310],"growth":[313],"inhibition":[314],"lower":[316],"doses.":[317],"on":[324],"larger,":[325],"established":[326],"(>1000":[328],"mm3).":[329],"Conclusion:":[330],"These":[331],"results":[332],"support":[333],"selective":[340,389],"inhibitor,":[343],"strong":[345],"antitumor":[346],"range":[350],"proteins,":[354],"active":[360],"site":[361],"currently":[365],"being":[366],"Phase":[370,394],"clinical":[372,396],"study.":[373],"Citation":[374],"Format:":[375],"Mitchell":[376],"Keegan,":[377],"Keith":[378],"Wilcoxen,":[379],"Peter":[380],"T.":[381],"Ho.":[382],"BOS172738:":[383],"A":[384],"novel":[385],"highly":[386],"development":[397],"[abstract].":[398],"In:":[399],"Proceedings":[400],"American":[403],"Association":[404],"Cancer":[406,420],"Research":[407],"Annual":[408],"Meeting":[409],"2019;":[410],"2019":[411],"Mar":[412],"29-Apr":[413],"3;":[414],"Atlanta,":[415],"GA.":[416],"Philadelphia":[417],"(PA):":[418],"AACR;":[419],"Res":[421],"2019;79(13":[422],"Suppl):Abstract":[423],"nr":[424],"2199.":[425]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-07-12T00:00:00"}